nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent ethyl—DGAT1—myometrium—sarcoma	0.048	0.136	CbGeAlD
Icosapent ethyl—DGAT1—seminal vesicle—sarcoma	0.0434	0.123	CbGeAlD
Icosapent ethyl—DGAT1—hematopoietic system—sarcoma	0.0412	0.117	CbGeAlD
Icosapent ethyl—DGAT1—connective tissue—sarcoma	0.0397	0.112	CbGeAlD
Icosapent ethyl—DGAT1—skin of body—sarcoma	0.0359	0.101	CbGeAlD
Icosapent ethyl—DGAT1—cardiac atrium—sarcoma	0.0313	0.0886	CbGeAlD
Icosapent ethyl—DGAT1—tendon—sarcoma	0.0273	0.0772	CbGeAlD
Icosapent ethyl—DGAT1—bone marrow—sarcoma	0.0264	0.0748	CbGeAlD
Icosapent ethyl—DGAT1—testis—sarcoma	0.0226	0.0639	CbGeAlD
Icosapent ethyl—DGAT1—liver—sarcoma	0.0214	0.0604	CbGeAlD
Icosapent ethyl—DGAT1—lymph node—sarcoma	0.0164	0.0463	CbGeAlD
Icosapent ethyl—Myalgia—Thiotepa—sarcoma	0.00195	0.00302	CcSEcCtD
Icosapent ethyl—Dysgeusia—Mitoxantrone—sarcoma	0.00194	0.003	CcSEcCtD
Icosapent ethyl—Myalgia—Dactinomycin—sarcoma	0.00194	0.003	CcSEcCtD
Icosapent ethyl—Eructation—Doxorubicin—sarcoma	0.00192	0.00297	CcSEcCtD
Icosapent ethyl—Back pain—Mitoxantrone—sarcoma	0.00191	0.00296	CcSEcCtD
Icosapent ethyl—Discomfort—Dactinomycin—sarcoma	0.00191	0.00296	CcSEcCtD
Icosapent ethyl—Neoplasm—Epirubicin—sarcoma	0.00191	0.00295	CcSEcCtD
Icosapent ethyl—Melaena—Doxorubicin—sarcoma	0.00191	0.00295	CcSEcCtD
Icosapent ethyl—Colitis—Doxorubicin—sarcoma	0.00188	0.0029	CcSEcCtD
Icosapent ethyl—Infection—Thiotepa—sarcoma	0.00186	0.00288	CcSEcCtD
Icosapent ethyl—Oedema—Dactinomycin—sarcoma	0.00186	0.00287	CcSEcCtD
Icosapent ethyl—Fluid retention—Doxorubicin—sarcoma	0.00185	0.00287	CcSEcCtD
Icosapent ethyl—Infection—Dactinomycin—sarcoma	0.00184	0.00285	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Mitoxantrone—sarcoma	0.00184	0.00284	CcSEcCtD
Icosapent ethyl—Vertigo—Vincristine—sarcoma	0.00183	0.00283	CcSEcCtD
Icosapent ethyl—Tachycardia—Thiotepa—sarcoma	0.00183	0.00282	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Epirubicin—sarcoma	0.0018	0.00278	CcSEcCtD
Icosapent ethyl—Malaise—Mitoxantrone—sarcoma	0.00179	0.00276	CcSEcCtD
Icosapent ethyl—Anorexia—Thiotepa—sarcoma	0.00178	0.00276	CcSEcCtD
Icosapent ethyl—Anorexia—Dactinomycin—sarcoma	0.00177	0.00274	CcSEcCtD
Icosapent ethyl—Neoplasm—Doxorubicin—sarcoma	0.00177	0.00273	CcSEcCtD
Icosapent ethyl—Hypertension—Vincristine—sarcoma	0.00175	0.00272	CcSEcCtD
Icosapent ethyl—Myalgia—Vincristine—sarcoma	0.00173	0.00268	CcSEcCtD
Icosapent ethyl—Cough—Mitoxantrone—sarcoma	0.00173	0.00267	CcSEcCtD
Icosapent ethyl—Hypertension—Mitoxantrone—sarcoma	0.00171	0.00264	CcSEcCtD
Icosapent ethyl—Eczema—Epirubicin—sarcoma	0.00171	0.00264	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Thiotepa—sarcoma	0.0017	0.00264	CcSEcCtD
Icosapent ethyl—Chills—Etoposide—sarcoma	0.0017	0.00263	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00169	0.00262	CcSEcCtD
Icosapent ethyl—Chest pain—Mitoxantrone—sarcoma	0.00169	0.00261	CcSEcCtD
Icosapent ethyl—Arthralgia—Mitoxantrone—sarcoma	0.00169	0.00261	CcSEcCtD
Icosapent ethyl—Myalgia—Mitoxantrone—sarcoma	0.00169	0.00261	CcSEcCtD
Icosapent ethyl—Alopecia—Etoposide—sarcoma	0.00167	0.00259	CcSEcCtD
Icosapent ethyl—Discomfort—Mitoxantrone—sarcoma	0.00167	0.00258	CcSEcCtD
Icosapent ethyl—Lymphadenopathy—Doxorubicin—sarcoma	0.00166	0.00257	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Vincristine—sarcoma	0.00166	0.00257	CcSEcCtD
Icosapent ethyl—Oedema—Vincristine—sarcoma	0.00166	0.00257	CcSEcCtD
Icosapent ethyl—Infection—Vincristine—sarcoma	0.00165	0.00255	CcSEcCtD
Icosapent ethyl—Dyspepsia—Thiotepa—sarcoma	0.00165	0.00255	CcSEcCtD
Icosapent ethyl—Increased appetite—Epirubicin—sarcoma	0.00163	0.00252	CcSEcCtD
Icosapent ethyl—Decreased appetite—Thiotepa—sarcoma	0.00163	0.00252	CcSEcCtD
Icosapent ethyl—Oedema—Mitoxantrone—sarcoma	0.00162	0.0025	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Mitoxantrone—sarcoma	0.00162	0.0025	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Thiotepa—sarcoma	0.00162	0.0025	CcSEcCtD
Icosapent ethyl—Decreased appetite—Dactinomycin—sarcoma	0.00161	0.0025	CcSEcCtD
Icosapent ethyl—Dysgeusia—Etoposide—sarcoma	0.00161	0.00249	CcSEcCtD
Icosapent ethyl—Infection—Mitoxantrone—sarcoma	0.0016	0.00248	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Vincristine—sarcoma	0.0016	0.00248	CcSEcCtD
Icosapent ethyl—Pain—Thiotepa—sarcoma	0.0016	0.00248	CcSEcCtD
Icosapent ethyl—Constipation—Thiotepa—sarcoma	0.0016	0.00248	CcSEcCtD
Icosapent ethyl—Back pain—Etoposide—sarcoma	0.00159	0.00246	CcSEcCtD
Icosapent ethyl—Shock—Mitoxantrone—sarcoma	0.00159	0.00246	CcSEcCtD
Icosapent ethyl—Pain—Dactinomycin—sarcoma	0.00159	0.00246	CcSEcCtD
Icosapent ethyl—Anorexia—Vincristine—sarcoma	0.00158	0.00245	CcSEcCtD
Icosapent ethyl—Eczema—Doxorubicin—sarcoma	0.00158	0.00244	CcSEcCtD
Icosapent ethyl—Tachycardia—Mitoxantrone—sarcoma	0.00158	0.00244	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Mitoxantrone—sarcoma	0.00156	0.00242	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Thiotepa—sarcoma	0.00154	0.00239	CcSEcCtD
Icosapent ethyl—Anorexia—Mitoxantrone—sarcoma	0.00154	0.00238	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Dactinomycin—sarcoma	0.00153	0.00237	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Etoposide—sarcoma	0.00153	0.00236	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Vincristine—sarcoma	0.00151	0.00234	CcSEcCtD
Icosapent ethyl—Increased appetite—Doxorubicin—sarcoma	0.00151	0.00234	CcSEcCtD
Icosapent ethyl—Affect lability—Epirubicin—sarcoma	0.00151	0.00233	CcSEcCtD
Icosapent ethyl—Migraine—Epirubicin—sarcoma	0.00151	0.00233	CcSEcCtD
Icosapent ethyl—Insomnia—Vincristine—sarcoma	0.0015	0.00232	CcSEcCtD
Icosapent ethyl—Malaise—Etoposide—sarcoma	0.00148	0.0023	CcSEcCtD
Icosapent ethyl—Vertigo—Etoposide—sarcoma	0.00148	0.00229	CcSEcCtD
Icosapent ethyl—Body temperature increased—Thiotepa—sarcoma	0.00148	0.00229	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00147	0.00228	CcSEcCtD
Icosapent ethyl—Body temperature increased—Dactinomycin—sarcoma	0.00147	0.00227	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Epirubicin—sarcoma	0.00146	0.00225	CcSEcCtD
Icosapent ethyl—Mood swings—Epirubicin—sarcoma	0.00145	0.00225	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Etoposide—sarcoma	0.00145	0.00224	CcSEcCtD
Icosapent ethyl—Decreased appetite—Vincristine—sarcoma	0.00144	0.00223	CcSEcCtD
Icosapent ethyl—Dyspnoea—Mitoxantrone—sarcoma	0.00144	0.00223	CcSEcCtD
Icosapent ethyl—Cough—Etoposide—sarcoma	0.00144	0.00222	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Vincristine—sarcoma	0.00143	0.00222	CcSEcCtD
Icosapent ethyl—Dyspepsia—Mitoxantrone—sarcoma	0.00142	0.0022	CcSEcCtD
Icosapent ethyl—Hypertension—Etoposide—sarcoma	0.00142	0.0022	CcSEcCtD
Icosapent ethyl—Pain—Vincristine—sarcoma	0.00142	0.00219	CcSEcCtD
Icosapent ethyl—Constipation—Vincristine—sarcoma	0.00142	0.00219	CcSEcCtD
Icosapent ethyl—Decreased appetite—Mitoxantrone—sarcoma	0.0014	0.00217	CcSEcCtD
Icosapent ethyl—Chest pain—Etoposide—sarcoma	0.0014	0.00217	CcSEcCtD
Icosapent ethyl—Affect lability—Doxorubicin—sarcoma	0.0014	0.00216	CcSEcCtD
Icosapent ethyl—Migraine—Doxorubicin—sarcoma	0.0014	0.00216	CcSEcCtD
Icosapent ethyl—Discomfort—Etoposide—sarcoma	0.00138	0.00214	CcSEcCtD
Icosapent ethyl—Constipation—Mitoxantrone—sarcoma	0.00138	0.00214	CcSEcCtD
Icosapent ethyl—Pain—Mitoxantrone—sarcoma	0.00138	0.00214	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.00138	0.00214	CcSEcCtD
Icosapent ethyl—Gastritis—Epirubicin—sarcoma	0.00136	0.0021	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Epirubicin—sarcoma	0.00135	0.00209	CcSEcCtD
Icosapent ethyl—Cardiac arrest—Doxorubicin—sarcoma	0.00135	0.00209	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Etoposide—sarcoma	0.00134	0.00208	CcSEcCtD
Icosapent ethyl—Mood swings—Doxorubicin—sarcoma	0.00134	0.00208	CcSEcCtD
Icosapent ethyl—Asthenia—Thiotepa—sarcoma	0.00134	0.00208	CcSEcCtD
Icosapent ethyl—Infection—Etoposide—sarcoma	0.00134	0.00207	CcSEcCtD
Icosapent ethyl—Abdominal distension—Epirubicin—sarcoma	0.00133	0.00206	CcSEcCtD
Icosapent ethyl—Asthenia—Dactinomycin—sarcoma	0.00133	0.00206	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Mitoxantrone—sarcoma	0.00133	0.00206	CcSEcCtD
Icosapent ethyl—Influenza—Epirubicin—sarcoma	0.00132	0.00205	CcSEcCtD
Icosapent ethyl—Asthma—Epirubicin—sarcoma	0.00132	0.00205	CcSEcCtD
Icosapent ethyl—Dysphagia—Epirubicin—sarcoma	0.00132	0.00205	CcSEcCtD
Icosapent ethyl—Pruritus—Thiotepa—sarcoma	0.00132	0.00205	CcSEcCtD
Icosapent ethyl—Tachycardia—Etoposide—sarcoma	0.00131	0.00203	CcSEcCtD
Icosapent ethyl—Body temperature increased—Vincristine—sarcoma	0.00131	0.00203	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Etoposide—sarcoma	0.0013	0.00201	CcSEcCtD
Icosapent ethyl—Pancreatitis—Epirubicin—sarcoma	0.0013	0.00201	CcSEcCtD
Icosapent ethyl—Angina pectoris—Epirubicin—sarcoma	0.00129	0.002	CcSEcCtD
Icosapent ethyl—Anorexia—Etoposide—sarcoma	0.00128	0.00198	CcSEcCtD
Icosapent ethyl—Body temperature increased—Mitoxantrone—sarcoma	0.00128	0.00198	CcSEcCtD
Icosapent ethyl—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.00128	0.00198	CcSEcCtD
Icosapent ethyl—Bronchitis—Epirubicin—sarcoma	0.00127	0.00197	CcSEcCtD
Icosapent ethyl—Gastritis—Doxorubicin—sarcoma	0.00126	0.00194	CcSEcCtD
Icosapent ethyl—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.00125	0.00194	CcSEcCtD
Icosapent ethyl—Dizziness—Thiotepa—sarcoma	0.00124	0.00191	CcSEcCtD
Icosapent ethyl—Abdominal distension—Doxorubicin—sarcoma	0.00123	0.00191	CcSEcCtD
Icosapent ethyl—Asthma—Doxorubicin—sarcoma	0.00123	0.0019	CcSEcCtD
Icosapent ethyl—Influenza—Doxorubicin—sarcoma	0.00123	0.0019	CcSEcCtD
Icosapent ethyl—Dysphagia—Doxorubicin—sarcoma	0.00123	0.0019	CcSEcCtD
Icosapent ethyl—Pancreatitis—Doxorubicin—sarcoma	0.0012	0.00186	CcSEcCtD
Icosapent ethyl—Dyspnoea—Etoposide—sarcoma	0.0012	0.00185	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Epirubicin—sarcoma	0.00119	0.00185	CcSEcCtD
Icosapent ethyl—Angina pectoris—Doxorubicin—sarcoma	0.00119	0.00185	CcSEcCtD
Icosapent ethyl—Asthenia—Vincristine—sarcoma	0.00119	0.00184	CcSEcCtD
Icosapent ethyl—Vomiting—Thiotepa—sarcoma	0.00119	0.00184	CcSEcCtD
Icosapent ethyl—Pneumonia—Epirubicin—sarcoma	0.00119	0.00184	CcSEcCtD
Icosapent ethyl—Infestation—Epirubicin—sarcoma	0.00118	0.00183	CcSEcCtD
Icosapent ethyl—Infestation NOS—Epirubicin—sarcoma	0.00118	0.00183	CcSEcCtD
Icosapent ethyl—Vomiting—Dactinomycin—sarcoma	0.00118	0.00183	CcSEcCtD
Icosapent ethyl—Rash—Thiotepa—sarcoma	0.00118	0.00182	CcSEcCtD
Icosapent ethyl—Bronchitis—Doxorubicin—sarcoma	0.00118	0.00182	CcSEcCtD
Icosapent ethyl—Dermatitis—Thiotepa—sarcoma	0.00118	0.00182	CcSEcCtD
Icosapent ethyl—Rash—Dactinomycin—sarcoma	0.00117	0.00181	CcSEcCtD
Icosapent ethyl—Decreased appetite—Etoposide—sarcoma	0.00117	0.00181	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Etoposide—sarcoma	0.00116	0.00179	CcSEcCtD
Icosapent ethyl—Asthenia—Mitoxantrone—sarcoma	0.00116	0.00179	CcSEcCtD
Icosapent ethyl—Pain—Etoposide—sarcoma	0.00115	0.00178	CcSEcCtD
Icosapent ethyl—Constipation—Etoposide—sarcoma	0.00115	0.00178	CcSEcCtD
Icosapent ethyl—Sweating—Epirubicin—sarcoma	0.00113	0.00175	CcSEcCtD
Icosapent ethyl—Epistaxis—Epirubicin—sarcoma	0.00111	0.00172	CcSEcCtD
Icosapent ethyl—Sinusitis—Epirubicin—sarcoma	0.00111	0.00171	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Etoposide—sarcoma	0.00111	0.00171	CcSEcCtD
Icosapent ethyl—Hyperglycaemia—Doxorubicin—sarcoma	0.00111	0.00171	CcSEcCtD
Icosapent ethyl—Pneumonia—Doxorubicin—sarcoma	0.0011	0.0017	CcSEcCtD
Icosapent ethyl—Dizziness—Vincristine—sarcoma	0.0011	0.0017	CcSEcCtD
Icosapent ethyl—Infestation NOS—Doxorubicin—sarcoma	0.00109	0.00169	CcSEcCtD
Icosapent ethyl—Infestation—Doxorubicin—sarcoma	0.00109	0.00169	CcSEcCtD
Icosapent ethyl—Rhinitis—Epirubicin—sarcoma	0.00106	0.00164	CcSEcCtD
Icosapent ethyl—Body temperature increased—Etoposide—sarcoma	0.00106	0.00164	CcSEcCtD
Icosapent ethyl—Vomiting—Vincristine—sarcoma	0.00105	0.00163	CcSEcCtD
Icosapent ethyl—Pharyngitis—Epirubicin—sarcoma	0.00105	0.00163	CcSEcCtD
Icosapent ethyl—Sweating—Doxorubicin—sarcoma	0.00105	0.00162	CcSEcCtD
Icosapent ethyl—Rash—Vincristine—sarcoma	0.00105	0.00162	CcSEcCtD
Icosapent ethyl—Dermatitis—Vincristine—sarcoma	0.00104	0.00162	CcSEcCtD
Icosapent ethyl—Epistaxis—Doxorubicin—sarcoma	0.00103	0.00159	CcSEcCtD
Icosapent ethyl—Vomiting—Mitoxantrone—sarcoma	0.00103	0.00159	CcSEcCtD
Icosapent ethyl—Sinusitis—Doxorubicin—sarcoma	0.00103	0.00159	CcSEcCtD
Icosapent ethyl—Rash—Mitoxantrone—sarcoma	0.00102	0.00158	CcSEcCtD
Icosapent ethyl—Dermatitis—Mitoxantrone—sarcoma	0.00102	0.00157	CcSEcCtD
Icosapent ethyl—Rhinitis—Doxorubicin—sarcoma	0.000984	0.00152	CcSEcCtD
Icosapent ethyl—Pharyngitis—Doxorubicin—sarcoma	0.000974	0.00151	CcSEcCtD
Icosapent ethyl—Asthenia—Etoposide—sarcoma	0.000964	0.00149	CcSEcCtD
Icosapent ethyl—Chills—Epirubicin—sarcoma	0.000951	0.00147	CcSEcCtD
Icosapent ethyl—Pruritus—Etoposide—sarcoma	0.000951	0.00147	CcSEcCtD
Icosapent ethyl—Arrhythmia—Epirubicin—sarcoma	0.000947	0.00147	CcSEcCtD
Icosapent ethyl—Alopecia—Epirubicin—sarcoma	0.000937	0.00145	CcSEcCtD
Icosapent ethyl—Malnutrition—Epirubicin—sarcoma	0.000923	0.00143	CcSEcCtD
Icosapent ethyl—Dysgeusia—Epirubicin—sarcoma	0.000904	0.0014	CcSEcCtD
Icosapent ethyl—Back pain—Epirubicin—sarcoma	0.000893	0.00138	CcSEcCtD
Icosapent ethyl—Dizziness—Etoposide—sarcoma	0.000889	0.00137	CcSEcCtD
Icosapent ethyl—Chills—Doxorubicin—sarcoma	0.00088	0.00136	CcSEcCtD
Icosapent ethyl—Arrhythmia—Doxorubicin—sarcoma	0.000876	0.00136	CcSEcCtD
Icosapent ethyl—Alopecia—Doxorubicin—sarcoma	0.000867	0.00134	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Epirubicin—sarcoma	0.000856	0.00132	CcSEcCtD
Icosapent ethyl—Vomiting—Etoposide—sarcoma	0.000854	0.00132	CcSEcCtD
Icosapent ethyl—Malnutrition—Doxorubicin—sarcoma	0.000854	0.00132	CcSEcCtD
Icosapent ethyl—Rash—Etoposide—sarcoma	0.000847	0.00131	CcSEcCtD
Icosapent ethyl—Dermatitis—Etoposide—sarcoma	0.000847	0.00131	CcSEcCtD
Icosapent ethyl—Dysgeusia—Doxorubicin—sarcoma	0.000836	0.00129	CcSEcCtD
Icosapent ethyl—Malaise—Epirubicin—sarcoma	0.000832	0.00129	CcSEcCtD
Icosapent ethyl—Vertigo—Epirubicin—sarcoma	0.000829	0.00128	CcSEcCtD
Icosapent ethyl—Syncope—Epirubicin—sarcoma	0.000828	0.00128	CcSEcCtD
Icosapent ethyl—Back pain—Doxorubicin—sarcoma	0.000826	0.00128	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Epirubicin—sarcoma	0.000811	0.00126	CcSEcCtD
Icosapent ethyl—Cough—Epirubicin—sarcoma	0.000805	0.00125	CcSEcCtD
Icosapent ethyl—Hypertension—Epirubicin—sarcoma	0.000797	0.00123	CcSEcCtD
Icosapent ethyl—Ill-defined disorder—Doxorubicin—sarcoma	0.000792	0.00123	CcSEcCtD
Icosapent ethyl—Myalgia—Epirubicin—sarcoma	0.000786	0.00122	CcSEcCtD
Icosapent ethyl—Arthralgia—Epirubicin—sarcoma	0.000786	0.00122	CcSEcCtD
Icosapent ethyl—Chest pain—Epirubicin—sarcoma	0.000786	0.00122	CcSEcCtD
Icosapent ethyl—Discomfort—Epirubicin—sarcoma	0.000776	0.0012	CcSEcCtD
Icosapent ethyl—Malaise—Doxorubicin—sarcoma	0.00077	0.00119	CcSEcCtD
Icosapent ethyl—Dry mouth—Epirubicin—sarcoma	0.000768	0.00119	CcSEcCtD
Icosapent ethyl—Vertigo—Doxorubicin—sarcoma	0.000767	0.00119	CcSEcCtD
Icosapent ethyl—Syncope—Doxorubicin—sarcoma	0.000766	0.00118	CcSEcCtD
Icosapent ethyl—Oedema—Epirubicin—sarcoma	0.000753	0.00117	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Epirubicin—sarcoma	0.000753	0.00117	CcSEcCtD
Icosapent ethyl—Loss of consciousness—Doxorubicin—sarcoma	0.000751	0.00116	CcSEcCtD
Icosapent ethyl—Infection—Epirubicin—sarcoma	0.000748	0.00116	CcSEcCtD
Icosapent ethyl—Cough—Doxorubicin—sarcoma	0.000745	0.00115	CcSEcCtD
Icosapent ethyl—Shock—Epirubicin—sarcoma	0.000741	0.00115	CcSEcCtD
Icosapent ethyl—Hypertension—Doxorubicin—sarcoma	0.000737	0.00114	CcSEcCtD
Icosapent ethyl—Tachycardia—Epirubicin—sarcoma	0.000735	0.00114	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Epirubicin—sarcoma	0.000728	0.00113	CcSEcCtD
Icosapent ethyl—Arthralgia—Doxorubicin—sarcoma	0.000727	0.00112	CcSEcCtD
Icosapent ethyl—Myalgia—Doxorubicin—sarcoma	0.000727	0.00112	CcSEcCtD
Icosapent ethyl—Chest pain—Doxorubicin—sarcoma	0.000727	0.00112	CcSEcCtD
Icosapent ethyl—Discomfort—Doxorubicin—sarcoma	0.000718	0.00111	CcSEcCtD
Icosapent ethyl—Anorexia—Epirubicin—sarcoma	0.000718	0.00111	CcSEcCtD
Icosapent ethyl—Dry mouth—Doxorubicin—sarcoma	0.000711	0.0011	CcSEcCtD
Icosapent ethyl—Anaphylactic shock—Doxorubicin—sarcoma	0.000697	0.00108	CcSEcCtD
Icosapent ethyl—Oedema—Doxorubicin—sarcoma	0.000697	0.00108	CcSEcCtD
Icosapent ethyl—Infection—Doxorubicin—sarcoma	0.000692	0.00107	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000686	0.00106	CcSEcCtD
Icosapent ethyl—Shock—Doxorubicin—sarcoma	0.000686	0.00106	CcSEcCtD
Icosapent ethyl—Insomnia—Epirubicin—sarcoma	0.000681	0.00105	CcSEcCtD
Icosapent ethyl—Tachycardia—Doxorubicin—sarcoma	0.00068	0.00105	CcSEcCtD
Icosapent ethyl—Hyperhidrosis—Doxorubicin—sarcoma	0.000674	0.00104	CcSEcCtD
Icosapent ethyl—Dyspnoea—Epirubicin—sarcoma	0.000672	0.00104	CcSEcCtD
Icosapent ethyl—Anorexia—Doxorubicin—sarcoma	0.000664	0.00103	CcSEcCtD
Icosapent ethyl—Dyspepsia—Epirubicin—sarcoma	0.000663	0.00103	CcSEcCtD
Icosapent ethyl—Decreased appetite—Epirubicin—sarcoma	0.000655	0.00101	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Epirubicin—sarcoma	0.00065	0.00101	CcSEcCtD
Icosapent ethyl—Pain—Epirubicin—sarcoma	0.000644	0.000997	CcSEcCtD
Icosapent ethyl—Constipation—Epirubicin—sarcoma	0.000644	0.000997	CcSEcCtD
Icosapent ethyl—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000635	0.000982	CcSEcCtD
Icosapent ethyl—Insomnia—Doxorubicin—sarcoma	0.00063	0.000975	CcSEcCtD
Icosapent ethyl—Dyspnoea—Doxorubicin—sarcoma	0.000621	0.000961	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Epirubicin—sarcoma	0.000621	0.00096	CcSEcCtD
Icosapent ethyl—Dyspepsia—Doxorubicin—sarcoma	0.000614	0.000949	CcSEcCtD
Icosapent ethyl—Decreased appetite—Doxorubicin—sarcoma	0.000606	0.000937	CcSEcCtD
Icosapent ethyl—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000602	0.000931	CcSEcCtD
Icosapent ethyl—Constipation—Doxorubicin—sarcoma	0.000596	0.000922	CcSEcCtD
Icosapent ethyl—Pain—Doxorubicin—sarcoma	0.000596	0.000922	CcSEcCtD
Icosapent ethyl—Body temperature increased—Epirubicin—sarcoma	0.000595	0.000921	CcSEcCtD
Icosapent ethyl—Feeling abnormal—Doxorubicin—sarcoma	0.000574	0.000889	CcSEcCtD
Icosapent ethyl—Body temperature increased—Doxorubicin—sarcoma	0.000551	0.000852	CcSEcCtD
Icosapent ethyl—Asthenia—Epirubicin—sarcoma	0.00054	0.000836	CcSEcCtD
Icosapent ethyl—Pruritus—Epirubicin—sarcoma	0.000533	0.000825	CcSEcCtD
Icosapent ethyl—Asthenia—Doxorubicin—sarcoma	0.0005	0.000774	CcSEcCtD
Icosapent ethyl—Dizziness—Epirubicin—sarcoma	0.000498	0.000771	CcSEcCtD
Icosapent ethyl—Pruritus—Doxorubicin—sarcoma	0.000493	0.000763	CcSEcCtD
Icosapent ethyl—Vomiting—Epirubicin—sarcoma	0.000479	0.000741	CcSEcCtD
Icosapent ethyl—Rash—Epirubicin—sarcoma	0.000475	0.000735	CcSEcCtD
Icosapent ethyl—Dermatitis—Epirubicin—sarcoma	0.000475	0.000734	CcSEcCtD
Icosapent ethyl—Dizziness—Doxorubicin—sarcoma	0.000461	0.000713	CcSEcCtD
Icosapent ethyl—Vomiting—Doxorubicin—sarcoma	0.000443	0.000686	CcSEcCtD
Icosapent ethyl—Rash—Doxorubicin—sarcoma	0.000439	0.00068	CcSEcCtD
Icosapent ethyl—Dermatitis—Doxorubicin—sarcoma	0.000439	0.000679	CcSEcCtD
